Article Text

Download PDFPDF
miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2
  1. Hongliang Diao1,
  2. Zhou Ye1,
  3. Renyi Qin2
  1. 1 Department of General Surgery, Karamay Central Hospital, Karamay, Xinjiang, China
  2. 2 Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
  1. Correspondence to Dr Renyi Qin, Department of biliary-pancreatic surgey, Affiliated Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030 , China; renyiqin2017{at}


MicroRNAs have been reported to play an important role in tumor development and progression by targeting oncogenes and tumor suppressors. miR-23a has been described as significantly upregulated in multiple cancers and involved in tumorigenesis. The aim of this study was to evaluate the potential roles of miR-23a in pancreatic ductal adenocarcinoma (PDAC). We found that miR-23a level was significantly increased in tissues of PDAC compared with that in the control by real-time PCR. FOXP2 expression was downregulated and inversely correlated with miR-23a. miR-23a directly targeted the 3’-untranslated region of FOXP2 mRNA and repressed its expression. Mechanistically, enhancement of miR-23a by transfection with mimics in Aspc-1 cells significantly promoted cell proliferation and invasion, while miR-23a inhibitors transfection in SW1990 cells induced an inhibitory effect. Moreover, restoration of FOXP2 impaired the pro-proliferation and proinvasion effects of miR-23a, indicating FOXP2 is a direct mediator of miR-23a functions. In conclusion, our findings suggest a novel miR-23a/FOXP2 link contributing to PDAC development and invasion. It may be a potential diagnostic and therapeutic target for PDAC.

  • miR-23a
  • FOXP2
  • proliferation
  • invasion

Statistics from


  • Contributors HD and ZY performed the experiments. ZY analysed the data. HD and RQ designed the study and wrote the manuscript.

  • Competing interests None declared.

  • Ethics approval The study was performed with the approval of the Medical Ethics Committee of Central Hospital based in the Xinjiang Uygur Autonomous Region and conducted according to the principles expressed in the Declaration of Helsinki.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement All of the data were published and available when required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.